Literature DB >> 8955927

Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.

J H Su1, B J Cummings, C W Cotman.   

Abstract

Paired helical filament (PHF)/tau immunoreactive dystrophic neurites are a common pathological feature in the brain of patients with Alzheimer's disease. Recent studies suggest that swollen neurofilament-immunoreactive neurites are also present in senile plaques. In the present study, we investigated whether PHF/tau-positive dystrophic neurites are located in all subtypes of plaques and whether swollen neurofilament-immunoreactive neurites are hyper-phosphorylated, using a battery of antibodies to PHF/tau, neurofilament, and beta-amyloid protein. PHF/tau-positive dystrophic neurites were present in and around nearly all subtypes of plaques, including small amyloid deposits, diffuse plaques, and perivascular plaques in the hippocampal formation of Alzheimer brain. The earlier changes were detectable with AT8 antibody and later changes with PHF-1 antibody. Plaque-associated PHF/tau-positive dystrophic neurites were rare or absent in the hippocampal formation of normal aged brain. Swollen neurofilament-positive neurites appeared to be hyper-phosphorylated in Alzheimer's disease and to a lesser degree in aged control brains. Neurites that contained hyper-phosphorylated tau as well as neurofilament were strongly argentophilic because both populations of dystrophic neurites stained with silver stains. Swollen neurofilament-positive plaque-associated neurites were often present in the absence of PHF/tau-positive plaque-associated dystrophic neurites. These data suggest that PHF/tau-positive dystrophic neurites are a common component of all subtypes of plaques in Alzheimer brain and neurofilament protein in swollen neurites, like tau protein, is hyper-phosphorylated. Hyper-phosphorylated neurofilaments in plaque-associated neurites may represent one of the earliest cytoskeletal changes in vulnerable neurons in Alzheimer's disease and aged control brains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955927     DOI: 10.1016/s0006-8993(96)00811-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo.

Authors:  J G Sheng; S G Zhu; R A Jones; W S Griffin; R E Mrak
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

2.  Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.

Authors:  Pierre De Rossi; Robert J Andrew; Timothy F Musial; Virginie Buggia-Prevot; Guilian Xu; Moorthi Ponnusamy; Han Ly; Sofia V Krause; Richard C Rice; Valentine de l'Estoile; Tess Valin; Someya Salem; Florin Despa; David R Borchelt; Vytas P Bindokas; Daniel A Nicholson; Gopal Thinakaran
Journal:  Brain Pathol       Date:  2018-12-27       Impact factor: 6.508

3.  Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.

Authors:  Peng Liu; John H Reichl; Eshaan R Rao; Brittany M McNellis; Eric S Huang; Laura S Hemmy; Colleen L Forster; Michael A Kuskowski; David R Borchelt; Robert Vassar; Karen H Ashe; Kathleen R Zahs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Alona Muzikansky; Teresa Gómez-Isla; John H Growdon; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2013-06       Impact factor: 3.685

5.  C-terminal fragments of amyloid-beta peptide cause cholinergic axonal degeneration by a toxic effect rather than by physical injury in the nondemented human brain.

Authors:  Peter Kasa; Henrietta Papp; Janos Zombori; Peter Mayer; Frederic Checler
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

6.  Axonal damage in multiple sclerosis.

Authors:  Jeffery D Haines; Matilde Inglese; Patrizia Casaccia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

Review 7.  Does beta-amyloid plaque formation cause structural injury to neuronal processes?

Authors:  Adele Woodhouse; Adrian K West; Jyoti A Chuckowree; James C Vickers; Tracey C Dickson
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Neurofilament proteins in Y-cells of the cat lateral geniculate nucleus: normal expression and alteration with visual deprivation.

Authors:  M E Bickford; W Guido; D W Godwin
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

Review 9.  Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2016-06-23       Impact factor: 3.911

Review 10.  A vaccine against Alzheimer's disease: developments to date.

Authors:  James C Vickers
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.